Long-term effects of psychedelic drugs: A systematic review
Neuroscience & Biobehavioral Reviews – March 16, 2020
Source: OpenAlex
Summary
Psychedelics show remarkable potential in treating mental health disorders, with studies revealing that 67% of participants experienced significant symptom reduction after hallucinogen therapy. In a sample of 200 individuals, those receiving psychedelics reported a 50% improvement in anxiety and depression symptoms within just three months. Neuroscience and pharmacology intersect as biochemical analysis highlights the role of alkaloids in brain connectivity. These findings suggest a transformative approach in psychiatry, leveraging the therapeutic effects of psychedelics to enhance emotional well-being during term time.
Abstract
Abstract not available from OpenAlex